6-((6-(4-(Trifluoromethyl)phenyl)-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)quinoline

ID: ALA4539488

PubChem CID: 86566672

Max Phase: Preclinical

Molecular Formula: C22H14F3N5

Molecular Weight: 405.38

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  FC(F)(F)c1ccc(-c2cnc3ncn(Cc4ccc5ncccc5c4)c3n2)cc1

Standard InChI:  InChI=1S/C22H14F3N5/c23-22(24,25)17-6-4-15(5-7-17)19-11-27-20-21(29-19)30(13-28-20)12-14-3-8-18-16(10-14)2-1-9-26-18/h1-11,13H,12H2

Standard InChI Key:  TYYYYDCCDUCSIO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   37.8535   -1.6921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8524   -2.5117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5604   -2.9206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.5586   -1.2833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.2673   -1.6885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2675   -2.5117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0505   -2.7659    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.5342   -2.0997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0501   -1.4340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.3032   -3.5430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1026   -3.7127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3528   -4.4893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1513   -4.6592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6444   -3.1049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4424   -3.2711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6977   -4.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4996   -4.2192    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.0470   -3.6074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7868   -2.8253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9856   -2.6613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1462   -2.9200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4386   -2.5091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7310   -2.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7299   -3.7345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4423   -4.1435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1469   -3.7338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0224   -4.1435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3145   -3.7353    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.0229   -4.9607    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   34.3097   -4.5441    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 16  2  0
 15 14  2  0
 14 11  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
  2 21  1  0
 24 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
M  END

Associated Targets(Human)

MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1993 (343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.38Molecular Weight (Monoisotopic): 405.1201AlogP: 5.11#Rotatable Bonds: 3
Polar Surface Area: 56.49Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.55CX LogP: 4.53CX LogD: 4.53
Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.42Np Likeness Score: -1.47

References

1. Zhao F, Zhang J, Zhang L, Hao Y, Shi C, Xia G, Yu J, Liu Y..  (2016)  Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase.,  24  (18): [PMID:27448775] [10.1016/j.bmc.2016.07.019]

Source